DK0830600T3 - Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister - Google Patents

Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister

Info

Publication number
DK0830600T3
DK0830600T3 DK96918089T DK96918089T DK0830600T3 DK 0830600 T3 DK0830600 T3 DK 0830600T3 DK 96918089 T DK96918089 T DK 96918089T DK 96918089 T DK96918089 T DK 96918089T DK 0830600 T3 DK0830600 T3 DK 0830600T3
Authority
DK
Denmark
Prior art keywords
gpcrs
antagonists
identify
indicator cells
protein
Prior art date
Application number
DK96918089T
Other languages
English (en)
Inventor
David I Israel
Christopher J Molineaux
Original Assignee
Praecis Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23905512&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0830600(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Praecis Pharm Inc filed Critical Praecis Pharm Inc
Application granted granted Critical
Publication of DK0830600T3 publication Critical patent/DK0830600T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK96918089T 1995-06-07 1996-06-05 Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister DK0830600T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47980395A 1995-06-07 1995-06-07
PCT/US1996/008895 WO1996041169A1 (en) 1995-06-07 1996-06-05 Functional bioassay for g-protein coupled receptor agonists and antagonists

Publications (1)

Publication Number Publication Date
DK0830600T3 true DK0830600T3 (da) 2003-12-22

Family

ID=23905512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918089T DK0830600T3 (da) 1995-06-07 1996-06-05 Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister

Country Status (8)

Country Link
EP (1) EP0830600B1 (da)
JP (1) JPH11507518A (da)
AT (1) ATE248373T1 (da)
AU (1) AU730875C (da)
CA (1) CA2220715C (da)
DE (1) DE69629684T2 (da)
DK (1) DK0830600T3 (da)
WO (1) WO1996041169A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2186979A1 (en) * 1996-10-02 1998-04-02 Michael Dennis Methods of testing antagonists for their abilities to affect the activity of g protein-coulpled receptors
CA2192754A1 (en) 1996-12-12 1998-06-12 Jacques Drouin Nur-re a response element which binds dimers of nur nuclear receptors and method of use therefor
US6403305B1 (en) * 1997-02-06 2002-06-11 Cornell Research Foundation, Inc. Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor
EP0878542A3 (en) * 1997-04-22 2000-04-19 Smithkline Beecham Corporation cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
EP0874047A3 (en) * 1997-04-22 2000-04-19 Smithkline Beecham Corporation cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
US20020146740A1 (en) * 1997-10-09 2002-10-10 William D. Huse Method for identifying optimal binding ligands to a receptor
MXPA01001176A (es) * 1998-07-31 2005-07-25 Arena Pharm Inc Receptores huerfanos acoplados a la proteina g constitutivamente activados endogenos.
EP1242824A2 (en) * 1999-12-30 2002-09-25 7TM Pharma Screening using biological target molecules with metal-ion binding sites
JP4908721B2 (ja) * 2000-07-17 2012-04-04 中外製薬株式会社 生理活性を有するリガンドのスクリーニング方法
US6902902B2 (en) * 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
EP2490021A1 (en) * 2011-02-18 2012-08-22 Biotempt B.V. Modulators of PRR and GPCR signalling
KR101452864B1 (ko) 2011-11-17 2014-11-04 서울대학교산학협력단 Ｇｐｃｒ19 경로의 활성화에 의한 골수 유래 면역 조절 세포 및 면역 조절 ｂ 림프구의 체내외 증폭

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003137A1 (en) * 1991-08-07 1993-02-18 Washington University Human substance p receptor
CA2138999C (en) * 1992-06-23 2010-02-23 Stuart C. Sealfon Cloning and expression of gonadotropin-releasing hormone receptor
AU5361294A (en) * 1992-10-15 1994-05-09 Merck & Co., Inc. Cho cells expressing human endothelin receptors
GB2283239A (en) * 1993-10-29 1995-05-03 Ucb Sa Human H1 histamine receptor
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor

Also Published As

Publication number Publication date
AU6043796A (en) 1996-12-30
AU730875C (en) 2003-01-16
EP0830600A4 (en) 2000-04-05
JPH11507518A (ja) 1999-07-06
ATE248373T1 (de) 2003-09-15
AU730875B2 (en) 2001-03-15
DE69629684D1 (de) 2003-10-02
DE69629684T2 (de) 2004-02-26
EP0830600A1 (en) 1998-03-25
WO1996041169A1 (en) 1996-12-19
CA2220715A1 (en) 1996-12-19
CA2220715C (en) 2004-11-02
EP0830600B1 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
DK0830600T3 (da) Funktionelt bioassay for G-proteinkoblede receptoragonister og -antagonister
Moore et al. Cell-based versus isolated target screening: how lucky do you feel?
Sugden et al. Melatonin receptor pharmacology: toward subtype specificity
Gao et al. Allosteric modulation and functional selectivity of G protein-coupled receptors
Neher et al. Intracellular calcium release mediated by two muscarinic receptor subtypes
Liu et al. Gα16/z chimeras efficiently link a wide range of G protein–coupled receptors to calcium mobilization
ATE394493T1 (de) VERBESSERTE SYSTEME FÜR DEN EMPFINDLICHEN NACHWEIS DER FUNKTION VON G-PROTEIN GEKOPPELTEN REZEPTOREN UND ßORPHANß-REZEPTOREN MITTELS KOMPLEMENTIERUNG VON MUTANTEN DES REPORTER-ENZYMS
ATE333518T1 (de) Verfahren zur identifizierug oder testung von agonisten für bzw. antagonisten gegen ppar
CA2279881A1 (en) A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
Onaran et al. Conceptual and experimental issues in biased agonism
Price et al. FlexStation examination of 5-HT3 receptor function using Ca2+-and membrane potential-sensitive dyes: advantages and potential problems
EP1266037B1 (en) High throughput screening by measurement of intracellular calcium levels
Allen et al. A homogeneous high throughput nonradioactive method for measurement of functional activity of Gs-coupled receptors in membranes
Reinscheid et al. High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotide-gated channels
Zhang et al. Action of alpha 2A-adrenergic receptors in circular smooth muscle of canine proximal colon
Lundin et al. Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells
Allan et al. An ultrahigh-throughput screening assay for estrogen receptor ligands
WO1999055901A3 (en) Screening assay for identifying human purinoreceptor ligands
Lovenberg et al. D1 dopamine receptors of NS20Y neuroblastoma cells are functionally similar to rat striatal D1 receptors
Davenport et al. Radioligand-binding and molecular-imaging techniques for the quantitative analysis of established and emerging orphan receptor systems
Crouch et al. New strategies in drug discovery for GPCRs: high throughput detection of cellular ERK phosphorylation
JP2002521681A5 (da)
Goetz et al. A combination assay for simultaneous assessment of multiple signaling pathways
Gorbet et al. A miniature radioimmunoassay for melatonin for use with small samples from invertebrates
Kowal et al. Functional calcium coupling with the human metabotropic glutamate receptor subtypes 2 and 4 by stable co-expression with a calcium pathway facilitating G-protein chimera in Chinese hamster ovary cells